Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines.

Avantax Advisory Services Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.7% ...

Analysts at Craig Hallum assumed coverage on shares of Veracyte (NASDAQ:VCYT – Get Free Report) in a note issued to investors ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

In a notable sell-off, ARK reduced its holdings in Illumina Inc (NASDAQ: ILMN ), offloading a total of 42,616 shares. While the specific dollar value of this transaction was not provided, it follows a ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

Investing.com -- Shares of Impact BioMedical Inc. (NYSE American: IBO) skyrocketed, more than doubling in value during the recent trading session. The biotechnology firm’s stock rose over 150%, a ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

A less-than-encouraging clinical trial for an investigative medicine was the news driving down Incyte (NASDAQ: INCY) stock ...

Here’s what happened after RFK Jr. paused Peninsula company's half-billion-dollar vaccine contract. Spoiler alert: It wasn’t ...

Adaptive Biotechnologies (NASDAQ:ADPT) stock rises as Goldman Sachs upgrades to 'Buy,' citing an attractive end market. Read more here.

The approval expands the indication for Amvuttra, which now becomes the first and only therapeutic approved by the FDA for ...